top of page
Australia's R&D Tax Incentive
Do you know how to assess your R&D Tax incentive eligibility?
Why you should bring your clinical trial journey to Australia
The Research and Development Tax Incentive is an initiative launched by the Australian Federal Government to stimulate and encourage R&D across Australia.
This means you can get up to 43.5% cash rebate on your eligible R&D expenditure!
Speed of clinical trials
Accelerate your timeline through streamlined regulatory pathways while accessing elite research infrastructure and globally recognized data standards.
Financial Incentives
With generous tax rebates, you can receive a potential cash refund of 43.5% of every dollar spent in Australia on your R&D.
Regulatory Certainty
Benefit from a highly reliable regulatory environment governed by Australia's Therapeutic Goods Administration (TGA), ensuring seamless international alignment.
43.5% refundable tax offset is available to companies with an annual turnover of less than $20 million.
38.5% non refundable tax offset is available to companies with an annual turnover of more than $20 million.
Eligible Activities for R&D Tax Incentives
-
Include development of new knowledge (including new or improved products, processes, services, technologies, etc)
-
Be conducted in a scientific manner, progressing from hypothesis to experiment, observation and evaluation, leading to a conclusion
-
Have an outcome which is unknown or determined in advance on the basis of current available knowledge, information or experience.
Ready to maximise your R&D potential?
bottom of page